Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 10
1964 7
1965 3
1966 3
1967 6
1968 10
1969 14
1970 15
1971 11
1972 12
1973 12
1974 24
1975 7
1976 20
1977 11
1978 10
1979 14
1980 14
1981 13
1982 24
1983 24
1984 30
1985 20
1986 24
1987 21
1988 49
1989 69
1990 71
1991 75
1992 74
1993 64
1994 91
1995 77
1996 76
1997 70
1998 88
1999 89
2000 95
2001 73
2002 118
2003 113
2004 108
2005 122
2006 154
2007 152
2008 180
2009 139
2010 158
2011 141
2012 142
2013 189
2014 170
2015 206
2016 190
2017 186
2018 206
2019 201
2020 190
2021 161
2022 181
2023 184
2024 41

Text availability

Article attribute

Article type

Publication date

Search Results

4,672 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Treatment Options in Scleroderma: Recommendations and Comprehensive Review.
Zhao M, Wu J, Wu H, Sawalha AH, Lu Q. Zhao M, et al. Clin Rev Allergy Immunol. 2022 Apr;62(2):273-291. doi: 10.1007/s12016-020-08831-4. Epub 2021 Jan 15. Clin Rev Allergy Immunol. 2022. PMID: 33449302 Review.
There are two major clinical subsets of scleroderma: (i) systemic sclerosis (SSc) is a complex systemic autoimmune disorder characterized by inflammation, vasculopathy, and excessive fibrosis of the skin and multiple internal organs and (ii) localized …
There are two major clinical subsets of scleroderma: (i) systemic sclerosis (SSc) is a complex systemic autoimmune diso …
Systemic sclerosis.
Denton CP, Khanna D. Denton CP, et al. Lancet. 2017 Oct 7;390(10103):1685-1699. doi: 10.1016/S0140-6736(17)30933-9. Epub 2017 Apr 13. Lancet. 2017. PMID: 28413064 Review.
Systemic sclerosis, also called scleroderma, is an immune-mediated rheumatic disease that is characterised by fibrosis of the skin and internal organs and vasculopathy. Although systemic sclerosis is uncommon, it has a high morbidity and mortality. ...
Systemic sclerosis, also called scleroderma, is an immune-mediated rheumatic disease that is characterised by fibrosis of the …
Localized scleroderma: clinical spectrum and therapeutic update.
Careta MF, Romiti R. Careta MF, et al. An Bras Dermatol. 2015 Jan-Feb;90(1):62-73. doi: 10.1590/abd1806-4841.20152890. An Bras Dermatol. 2015. PMID: 25672301 Free PMC article. Review.
Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin an …
Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, an …
Pathophysiology of systemic sclerosis (scleroderma).
Rosendahl AH, Schönborn K, Krieg T. Rosendahl AH, et al. Kaohsiung J Med Sci. 2022 Mar;38(3):187-195. doi: 10.1002/kjm2.12505. Epub 2022 Mar 2. Kaohsiung J Med Sci. 2022. PMID: 35234358 Free article. Review.
Systemic sclerosis (scleroderma) is an autoimmune-triggered chronic fibrosing disease that affects the skin and many other organs. ...
Systemic sclerosis (scleroderma) is an autoimmune-triggered chronic fibrosing disease that affects the skin and many other org …
Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.
Ferreli C, Gasparini G, Parodi A, Cozzani E, Rongioletti F, Atzori L. Ferreli C, et al. Clin Rev Allergy Immunol. 2017 Dec;53(3):306-336. doi: 10.1007/s12016-017-8625-4. Clin Rev Allergy Immunol. 2017. PMID: 28712039 Review.
Scleroderma refers to an autoimmune connective tissue fibrosing disease, including three different subsets: localized scleroderma, limited cutaneous systemic sclerosis, and diffuse cutaneous systemic sclerosis with divergent patterns of organ in …
Scleroderma refers to an autoimmune connective tissue fibrosing disease, including three different subsets: localized scler …
Scleroderma in Children and Adolescents: Localized Scleroderma and Systemic Sclerosis.
Li SC. Li SC. Pediatr Clin North Am. 2018 Aug;65(4):757-781. doi: 10.1016/j.pcl.2018.04.002. Pediatr Clin North Am. 2018. PMID: 30031497 Review.
Scleroderma is a rare disease that has two main forms: localized scleroderma (LS) and systemic sclerosis (SSc). ...Mortality is extremely rare in juvenile LS, but morbidity is common, with patients at risk for severe disfigurement and functional impair …
Scleroderma is a rare disease that has two main forms: localized scleroderma (LS) and systemic sclerosis (SSc). …
Scleroderma epidemiology update.
Calderon LM, Pope JE. Calderon LM, et al. Curr Opin Rheumatol. 2021 Mar 1;33(2):122-127. doi: 10.1097/BOR.0000000000000785. Curr Opin Rheumatol. 2021. PMID: 33481429 Review.
PURPOSE OF REVIEW: Systemic sclerosis (scleroderma, SSc) is a rare multisystem autoimmune disease characterized by autoantibodies, vasculopathy, and fibrosis of the skin and internal organs. This review aims to provide an overview and summary of the recent epidemiol …
PURPOSE OF REVIEW: Systemic sclerosis (scleroderma, SSc) is a rare multisystem autoimmune disease characterized by autoantibod …
Upcoming treatments for morphea.
Wenzel D, Haddadi NS, Afshari K, Richmond JM, Rashighi M. Wenzel D, et al. Immun Inflamm Dis. 2021 Dec;9(4):1101-1145. doi: 10.1002/iid3.475. Epub 2021 Jul 17. Immun Inflamm Dis. 2021. PMID: 34272836 Free PMC article. Review.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. ...Insights into morphea pathogenesis are often extrapolated from studies of systemic s …
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an a …
Systemic sclerosis in adults. Part I: Clinical features and pathogenesis.
Jerjen R, Nikpour M, Krieg T, Denton CP, Saracino AM. Jerjen R, et al. J Am Acad Dermatol. 2022 Nov;87(5):937-954. doi: 10.1016/j.jaad.2021.10.065. Epub 2022 Feb 4. J Am Acad Dermatol. 2022. PMID: 35131402 Review.
Systemic sclerosis (SSc), also referred to as systemic scleroderma or scleroderma, is a rare, complex immune-mediated connective tissue disease characterized by progressive skin fibrosis and other clinically heterogenous features. ...The first article …
Systemic sclerosis (SSc), also referred to as systemic scleroderma or scleroderma, is a rare, complex immune-med …
Systemic sclerosis.
Hughes M, Herrick AL. Hughes M, et al. Br J Hosp Med (Lond). 2019 Sep 2;80(9):530-536. doi: 10.12968/hmed.2019.80.9.530. Br J Hosp Med (Lond). 2019. PMID: 31498665 Review.
Raynaud's phenomenon) is an almost universal symptom in patients with systemic sclerosis and is often the earliest manifestation of the disease. Systemic sclerosis not uncommonly can overlap with other rheumatological conditions (e.g. rheumatoid arthritis and myosit …
Raynaud's phenomenon) is an almost universal symptom in patients with systemic sclerosis and is often the earliest manifestation of t …
4,672 results